Applications of Luzindole in Industrial Manufacturing

Luzindole serves as a critical intermediate for advanced research and production in a variety of highly specialized industrial sectors. Our production meets rigorous purity and traceability requirements, supporting downstream users in regulated and innovative markets. Below is a detailed overview of key industrial applications for Luzindole based on established supply relationships and customer feedback.

1. Pharmaceutical Active Ingredient Manufacturing (Melatonin Antagonists Production)

Pharmaceutical companies employ Luzindole as a key synthetic intermediate in the preparation of experimental melatonin receptor antagonists for research-stage and pre-clinical drug candidates. Formulation chemists integrate this compound during the multi-step synthesis targeting selective binding compounds, often in structure-activity relationship (SAR) investigations under controlled conditions. Its use demands strict tracking under cGMP documentation, especially given the material’s impact on central nervous system pharmacology.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• 21 CFR Part 210/211 in the U.S., and EU GMP Vol. 4 (EudraLex)
• USP and EP Raw Material Quality Standards
• Pharmaceutical quality management system ISO 9001:2015

Typical usage ratio

• 0.2–2% w/w as a synthetic intermediate within multi-step APIs synthesis; final ratio depends on the molar design per target compound and batch size scaling

Downstream process integration

• Introduced at the intermediate stage within automated batch reactors under nitrogen atmosphere; combined with specific acid/base catalysts; followed by chromatographic purification

Final product types

• Preclinical and clinical grade melatonergic antagonists
• Pilot-scale small molecule investigational drug substances
• Reference standards for regulatory filings
• Building blocks for custom CNS-targeted pharmaceutical libraries

2. Neuroscience Research Reagent Supply (Laboratory Compound Kits)

Industrial laboratories and research reagent suppliers incorporate Luzindole as a reference antagonist in standardized analytical assay kits and pharmacological research panels. The material is dosed into controlled vials, lyophilized, or dissolved under inert conditions for subsequent use in in-vitro and in-vivo studies specific to melatonin receptor signaling inhibition. High batch purity and lot traceability remain necessary throughout packaging and distribution.

Industry compliance standards

• ISO 13485 for medical device and research reagent kits
• REACH (EC No 1907/2006) registration for laboratory chemicals in the EU
• OECD Good Laboratory Practice (GLP) for test material documentation
• Lot-specific Certificate of Analysis (COA) with HPLC/LC-MS verification >98%

Typical usage ratio

• 0.01–0.1 mg/vial for laboratory kits; concentration adjusted against assay specifications and intended test volumes; lyophilized or solution form

Downstream process integration

• Metered addition during reagent kit assembly under class 10000 cleanroom; subsequent sealing in inert atmosphere and batch/lot coding for end-user traceability

Final product types

• Pharmacology laboratory test kits for melatonin receptor blockers
• Cell culture additive panels for circadian rhythm research
• Bioassay calibration standards
• Ready-to-use neuroscience research compounds for academic labs

3. Veterinary Drug Development and Animal Health Research

Downstream R&D divisions utilize Luzindole in controlled animal model studies to probe pineal axis modulation and related behavioral endpoints. Preparation includes precise dilution and sterile filtration prior to in-vivo application, with full conformance to animal research controls. Regulatory oversight extends from substance receipt through archival post-study documentation, enforcing batch integrity throughout the supply chain.

Industry compliance standards

• Animal Welfare Act & Institutional Animal Care and Use Committee (IACUC) Protocols
• GLP–OECD No. 1 Basic Principles
• Material Safety Data Sheet (MSDS) with hazard communication, GHS-naming
• ISO/IEC 17025 Accreditation for animal pharmacology labs

Typical usage ratio

• 0.1–10 mg/kg bodyweight as determined by protocol; formulation as aqueous or buffered solution prior to administration

Downstream process integration

• Sterile compounding in biosafety class 2 environments; delivered to dosing station for scheduled animal administration; precise control of solution concentration and injection volume

Final product types

• Study-specific animal health compounds for neurobiological research
• Pilot veterinary investigational drugs
• Veterinary assay control reagents
• Preclinical animal model reference substances

4. Clinical Diagnostic Reagent Synthesis (Melatonin Pathway Analysis)

Diagnostic companies synthesize Luzindole-based reagents for use in clinical laboratory kits which measure melatonin and related hormones in human biological samples. The processes call for ultra-high purity preparations, validated through cross-lab proficiency testing, and integrated into automated immunoassay platforms. Each step, from batch receipt to lyophilization of finished reagent, requires exhaustive in-process and release testing to enable regulatory compliance for clinical diagnostics.

Industry compliance standards

• ISO 15189 Medical Laboratories – Requirements for Quality and Competence
• IVD Directive 98/79/EC (transitioning to IVDR Regulation (EU) 2017/746)
• CLSI (Clinical and Laboratory Standards Institute) Approved Guidelines for Calibration and Traceability
• FDA 21 CFR 820 Quality System Regulation for in-vitro diagnostic devices

Typical usage ratio

• 0.001–0.05% w/v in diagnostic reagent blends; optimized during kit validation relative to assay sensitivity targets and cross-reactivity minimization

Downstream process integration

• Dissolution in buffered matrices alongside co-reagents; precision aliquoting using cleanroom automated filling lines; followed by lyophilization and vacuum packaging

Final product types

• Clinical hormone immunoassay panels for circadian dysfunction diagnosis
• High-throughput ELISA kits for melatonin quantification
• Reference calibration standards used in regulated clinical labs
• Specialty diagnostic reagents for endocrine system testing

5. Custom Fine Chemical Synthesis (Contract Research & Custom Manufacturing)

Chemical contract research organizations (CROs) and custom synthesis units request Luzindole as a customizable scaffold for the creation of new indole derivatives or fluorescent probe analogs. Material shipped in bulk undergoes additional derivatization or labeled modifications by downstream chemists according to confidential customer specifications. Comprehensive lot traceability, impurity profiling by NMR and LC-MS, and support for detailed MSDS documentation represent critical workflow steps on every order.

Industry compliance standards

• ISO 9001:2015 for custom synthesis process management
• Chemical Facility Anti-Terrorism Standards (CFATS) for shipment and storage
• REACH registration for new substance evaluation in the EU
• Hazardous material documentation as per UN Globally Harmonized System (GHS)

Typical usage ratio

• Variable: 0.5–5 mmol scale for synthetic projects, with larger scale (up to kg) for pilot and process development; stoichiometry adjusted by specific target compound and patent process design

Downstream process integration

• Reaction vessel charging and coupling in high purity solvent systems; subsequent functionalization or isotope labeling; final purification by preparative HPLC or crystallization, with strict in-process QC

Final product types

• Novel indole analogs for pharmaceutical lead development
• Labeled standards for quantitative bioanalysis
• Chemical research tools for contract assay developers
• Proprietary intermediates for integrated supply chains